Hypothesis
Long‑term pharmacological suppression of pain‑activated mTOR or COX‑2 signaling blocks the autophagy surge that normally follows low‑intensity nociceptive input, converting a protective stress response into a driver of cellular senescence and accelerated aging.
Mechanistic Rationale
Pain stimuli activate neuropeptides such as substance P and CGRP, which trigger Ca²⁺‑dependent AMPK activation and downstream inhibition of mTORC1, unleashing autophagic flux that clears damaged mitochondria and protein aggregates (2). Analgesics that inhibit mTOR (e.g., rapamycin analogues) or COX‑2 derived prostaglandins blunt this AMPK‑mTOR axis, lowering ULK1 phosphorylation and impairing autophagosome formation (1). Consequently, p62 accumulates, LC3‑II turnover stalls, and damaged organelles persist, fostering oxidative stress and DNA damage that stabilize p53 and p16 (7). At the same time, blocked autophagy impairs the clearance of senescent cells themselves, allowing the SASP to amplify inflammaging (4). Thus, while acute pain relief is achieved, the chronic silencing of the damage‑sensing autophagy loop shifts the system from a hormetic repair mode to a senescent‑promoting state.
Novel Insight
We propose that the analgesic‑induced autophagy block creates a "senescence‑primed" niche in tissues where noc





























